V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260010041 | 260006360 | 1.73 | 69.5 | Curative (C) | 2017-09-06 | 2017-09-09 | EP | 01 | N | 260016880 | CISPLATIN + ETOPOSIDE |
| 260010042 | 260006360 | 1.63 | 74 | Curative (C) | 2014-12-01 | 2014-12-01 | Rituximab | 2 | N | 260016880 | CETUXIMAB |
| 260010043 | 260015732 | 1.81 | 96 | null | 2017-12-24 | 2018-01-01 | Carboplatin + Etoposide IV 3 day | null | null | 260016950 | CISPLATIN + ETOPOSIDE |
| 260010044 | 260006361 | 1.85 | 95.4 | null | null | 2016-11-13 | null | null | null | 260017081 | RITUXIMAB |
| 260010045 | 260006362 | 1.76 | 114.5 | Curative (C) | 2015-05-01 | 2015-05-01 | Cisplatin + Etoposide (3 day) | 1 | N | 260017152 | CARBOPLATIN + VINORELBINE |
| 260010046 | 260006362 | 1.85 | 0 | Curative (C) | 2016-11-30 | 2016-11-30 | Rituximab (INTRAVENOUS Maintenance) | 02 | N | 260017152 | NOT MATCHED |
| 260010047 | 260006363 | 1.63 | 63.5 | Palliative (P) | 2018-05-14 | 2018-05-16 | CISPLATIN + RT | 2 | N | 260017306 | RITUXIMAB |
| 260010048 | 260006363 | null | 81.8 | Neo-adjuvant (N) | 2018-11-20 | 2018-11-21 | VIP | 2 | N | 260017306 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260010049 | 260006363 | 1.79 | null | null | 2018-01-10 | 2018-01-10 | Rituximab | 01 | null | 260017306 | CHLORAMBUCIL + RITUXIMAB |
| 260010050 | 260006363 | 1.66 | 66 | Curative (C) | 2016-10-17 | 2017-01-22 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 260017306 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260010051 | 260006364 | 1.88 | 76 | Adjuvant (A) | 2015-06-12 | 2015-07-06 | ETOPOSIDE | N | Y | 260017772 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260010052 | 260006365 | 1.81 | 64 | Not known (9) | 2015-02-23 | 2015-03-07 | Cisplatin + Etoposide (3 day) | N | null | 260017849 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260010053 | 260006366 | 1.74 | 90.9 | Not known (9) | 2017-12-29 | 2017-12-30 | Carboplatin 21day + Paclitaxel 7day | N | null | 260017874 | RITUXIMAB |
| 260010054 | 260006367 | 1.81 | 103 | Neo-adjuvant (N) | 2018-11-21 | 2018-11-28 | CARBOPLATIN + ETOPOSIDE | N | N | 260017881 | CISPLATIN + ETOPOSIDE |
| 260010055 | 260012461 | 1.75 | 66.7 | Curative (C) | 2017-01-28 | 2017-02-02 | CISPLATIN + IFOSFAMIDE + VINBLASTINE | N | N | 260017935 | TIP |
| 260010056 | 260006368 | 1.65 | 58 | null | null | 2018-03-06 | Chlorambucil + Pred + Rituximab | null | null | 260017955 | RITUXIMAB |
| 260010057 | 260012462 | 1.55 | 81.9 | Disease modification (D) | 2017-06-05 | 2017-06-20 | Cisplatin + Pemetrexed | N | N | 260018036 | RITUXIMAB |
| 260010058 | 260006369 | 1.63 | 53.8 | Curative (C) | 2015-10-28 | 2015-11-01 | Rituximab | 02 | null | 260018101 | FEC |
| 260010059 | 260012463 | 1.67 | null | Curative (C) | 2018-09-06 | 2018-09-07 | Cisplatin + Paclitaxel | 2 | N | 260018283 | NOT MATCHED |
| 260010060 | 260006370 | 1.6 | 105.5 | Curative (C) | 2019-03-20 | 2019-03-20 | R Chlorambucil | N | N | 260018301 | RITUXIMAB |
| 260010061 | 260012464 | 1.7 | null | Curative (C) | 2016-12-06 | 2016-12-20 | Cisplatin + Etoposide (3 day) | 02 | N | 260018321 | CISPLATIN + ETOPOSIDE |
| 260010062 | 260012464 | 1.73 | null | Disease modification (D) | 2015-01-27 | 2015-02-13 | TIP | N | N | 260018321 | TIP |
| 260010063 | 260017490 | 1.75 | -1 | Curative (C) | 2017-08-31 | 2017-09-03 | Carboplatin + Etoposide IV 3 day | 02 | N | 260018371 | BENDAMUSTINE |
| 260010064 | 260006371 | 1.82 | 90 | Palliative (P) | 2018-04-13 | 2018-05-04 | Rituximab | 02 | N | 260018409 | GEMCITABINE + OXALIPLATIN |
| 260010065 | 260006371 | null | 91 | Curative (C) | null | 2017-11-27 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | Y | N | 260018409 | CVP R + GEMCITABINE |
| 260010066 | 260006371 | 1.65 | null | Curative (C) | 2018-01-05 | 2018-03-04 | 111 Trial (formerly BEP 111) | 02 | null | 260018409 | BOP |
| 260010067 | 260006372 | 1.74 | 80.7 | Not known (9) | 2016-07-19 | 2016-07-20 | Cisplatin + Etoposide (5 day) | 02 | null | 260018553 | CISPLATIN + ETOPOSIDE |
| 260010068 | 260006372 | 1.67 | 112.6 | Curative (C) | 2017-12-11 | 2017-12-14 | Rituximab | N | N | 260018553 | CISPLATIN + RT |
| 260010069 | 260006372 | null | 165 | Not known (9) | null | 2018-01-01 | EP | null | null | 260018553 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260010070 | 260006373 | null | 86 | Palliative (P) | 2015-07-30 | 2015-07-30 | CISPLATIN + ETOPOSIDE | 2 | N | 260018745 | NOT MATCHED |
| 260010071 | 260006374 | 1.78 | 72 | Palliative (P) | 2016-10-14 | 2016-10-14 | TIP | N | N | 260018853 | ETOPOSIDE |
| 260010072 | 260006374 | 1.7 | 56.4 | Disease modification (D) | 2018-08-11 | 2018-08-27 | R Chlorambucil | N | N | 260018853 | CETUXIMAB |
| 260010073 | 260006375 | 1.76 | 54 | Palliative (P) | null | 2018-07-04 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | null | null | 260018930 | PACIFICO TRIAL |
| 260010074 | 260006375 | 1.69 | 87 | Not known (9) | null | 2016-01-30 | TIP | null | null | 260018930 | CISPLATIN + ETOPOSIDE |
| 260010075 | 260006375 | 1.72 | 0 | Palliative (P) | 2016-06-16 | 2016-09-30 | Rituximab (Maintenance) | N | N | 260018930 | RITUXIMAB |
| 260010076 | 260006376 | null | 65 | null | null | 2016-05-03 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | null | 260019208 | EP |
| 260010077 | 260006377 | null | 67.6 | Palliative (P) | 2015-11-06 | 2015-11-13 | Cisplatin + Radiotherapy | 02 | N | 260019237 | CHLORAMBUCIL |
| 260010078 | 260006377 | 1.79 | 80.3 | Adjuvant (A) | null | 2014-11-21 | EP | null | null | 260019237 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260010079 | 260006378 | 1.79 | 79 | Curative (C) | 2017-02-05 | 2017-02-05 | POUT TRIAL | 02 | N | 260019243 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260010080 | 260012470 | 1.75 | 73.2 | Curative (C) | 2017-02-09 | 2017-02-14 | ICE + GCSF | N | N | 260019247 | TRIAL |
| 260010081 | 260012470 | null | 80 | Palliative (P) | 2016-11-06 | 2016-11-06 | EP | 2 | N | 260019247 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260010082 | 260012470 | 1.6 | 0 | Palliative (P) | 2018-07-01 | 2018-07-01 | CISPLATIN + RT | 02 | N | 260019247 | TRIAL |
| 260010083 | 260018405 | 1.65 | 56 | null | null | 2018-05-21 | Rituximab | N | null | 260019440 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260010084 | 260006379 | 1.53 | 72.8 | null | 2018-06-20 | 2018-06-24 | Rituximab | N | N | 260019465 | CARBOPLATIN + PACLITAXEL |
| 260010085 | 260006379 | 1.73 | 74 | Palliative (P) | null | 2017-08-08 | RCEOP | 2 | N | 260019465 | ETOPOSIDE |
| 260010086 | 260006379 | 1.81 | 101.7 | Palliative (P) | 2014-12-19 | 2015-01-23 | TIP | 2 | N | 260019465 | CISPLATIN + ETOPOSIDE |
| 260010087 | 260006380 | null | null | Palliative (P) | 2015-12-14 | 2015-12-26 | Cisplatin + Etoposide (3 day) | N | N | 260019645 | RITUXIMAB |
| 260010088 | 260012472 | 1.63 | null | null | 2018-06-29 | 2018-07-10 | FEC 60 or 75 | 02 | N | 260019672 | RITUXIMAB |
| 260010089 | 260012472 | 1.7 | 101.3 | Palliative (P) | 2016-09-01 | 2016-09-09 | Cisplatin + Etoposide (5 day) | 2 | N | 260019672 | NOT MATCHED |
| 260010090 | 260012472 | 1.78 | 55 | Curative (C) | 2013-11-09 | 2013-11-25 | EP | 2 | N | 260019672 | CARBOPLATIN + ETOPOSIDE |